These are known as symptomatic treatments. They include donepezil (part of a family of medicines called cholinesterase inhibitors) and memantine. These are available on the NHS. This type of ...

Consequently, combination therapy currently involves the administration of one cholinergic drug (donepezil, galantamine or rivastigmine) and one glutamatergic drug (memantine). There have been no ...

The introduction of generic Alzheimer’s and other dementia medications also resulted in a drop in OOP costs. Memantine prices ...

Benzgalantamine is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

Our NICE Advice service will guide you there. Get reliable scientific advice and NHS insights, direct from NICE. We support companies seeking nationwide adoption of the best treatments and care. Our ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

There are four dementia-specific medications approved in Australia – donepezil, galantamine, rivastigmine, and memantine. These available drugs offer symptomatic relief and are neither disease ...

More than 55 million people are currently living with dementia. Research into possible preventatives and treatments can’t ...

In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and ...

such as glutamate regulators (memantine) or an orexin receptor antagonist (suvorexant). These prescriptions can help symptoms affecting memory, attention, reasoning, and sleep-wake cycles by ...

Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...